Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVX | Common Stock | Options Exercise | $4.68M | +37.3K | $125.35 | 37.3K | Nov 30, 2022 | Direct | F1 | |
transaction | CVX | Common Stock | Sale | -$5.8M | -31.9K | -85.4% | $182.23 | 5.45K | Nov 30, 2022 | Direct | F1, F2 |
transaction | CVX | Common Stock | Sale | -$995K | -5.45K | -100% | $182.78 | 0 | Nov 30, 2022 | Direct | F1, F3 |
holding | CVX | Common Stock | 5.78K | Nov 30, 2022 | by 401(k) plan | ||||||
holding | CVX | Common Stock | 11.6K | Nov 30, 2022 | by JWJ Revocable Trust | ||||||
holding | CVX | Common Stock | 1K | Nov 30, 2022 | by Spouse Revocable Trust |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVX | Non-Qualified Stock Option (Right to Buy) | Options Exercise | $0 | -37.3K | -100% | $0.00* | 0 | Nov 30, 2022 | Common Stock | 37.3K | $125.35 | Direct | F4 |
Id | Content |
---|---|
F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2022. |
F2 | These shares were sold in multiple transactions at prices ranging from $181.73 to $182.72, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. |
F3 | These shares were sold in multiple transactions at prices ranging from $182.73 to $182.95, inclusive. The price reported in Column 4 reflects the weighted average sale price. |
F4 | Option granted January 31, 2018. One-third of the shares subject to the option vested on January 31, 2019, January 31, 2020 and January 31, 2021, respectively. |